Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Growing prevalence of orthopedic diseases
3.2.1.2 Technological advancements
3.2.1.3 Rising demand for knee pain injections
3.2.1.4 Therapeutics advantages to relieve joint pain & inflammation
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of joint pain injections
3.2.2.2 Side effects associated with joint pain injections
3.3 Growth potential analysis
3.4 Technological landscape
3.4.1 Stem cell therapy
3.4.2 Minimally invasive procedures
3.5 Pipeline analysis
3.6 Regulatory landscape
3.6.1 U.S.
3.6.2 Europe
3.7 Future market trends
3.8 Joint pain epidemiology scenario
3.9 Reimbursement scenario
3.10 Pricing analysis, 2023
3.11 Gap analysis
3.12 Porter's analysis
3.13 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.3.1 Global
4.3.2 North America
4.3.3 Europe
4.3.4 Asia Pacific
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Injection Type, 2018 – 2032 ($ Mn and Units)
5.1 Key trends
5.2 Hyaluronic acid injections
5.3 Corticosteroid injections
5.4 Platelet rich plasma injections
Chapter 6 Market Estimates and Forecast, By Joint Type, 2018 – 2032 ($ Mn and Units)
6.1 Key trends
6.2 Knee
6.3 Shoulder & elbow
6.4 Ankle & hip
6.5 Other joint types
Chapter 7 Market Estimates and Forecast, By End User, 2018 – 2032 ($ Mn and Units)
7.1 Key trends
7.2 Hospitals
7.3 Clinics
7.4 Other end users
Chapter 8 Market Estimates and Forecast, By Region, 2018 – 2032 ($ Mn and Units)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.6 Middle East and Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
Chapter 9 Company Profiles
9.1 Anika Therapeutics, Inc.
9.2 Arthrex
9.3 Bioventus
9.4 Emcyte Corporation
9.5 Ferring B.V.
9.6 Lifecore Biomedical
9.7 OrthogenRx
9.8 Pacira BioSciences (Flexion)
9.9 Pfizer, Inc.
9.10 Sanofi S.A.
9.11 Stryker Corporation
9.12 Zimmer Biomet Holdings, Inc.
